BCL6B (B-Cell CLL/Lymphoma 6 Member B Protein) Contributes to Ocular Vascular Diseases via Notch Signal Silencing.

Miruto TanakaShinsuke NakamuraTomohisa SakaueTakumi YamamotoMasashi MaekawaAnri NishinakaHiroto YasudaKaori YunokiYuji SatoMasaaki SawaKohichiro YoshinoMasamitsu ShimazawaMasahiko HatanoTakeshi TokuhisaShigeki HigashiyamaHideaki Hara

Published in: Arteriosclerosis, thrombosis, and vascular biology (2023)

These data indicate that BCL6B may be a novel therapeutic target for ocular vascular diseases characterized by ocular neovascularization and edema.

Keyphrases

optic nerve
diffuse large b cell lymphoma
electronic health record
cell proliferation
vascular endothelial growth factor
diabetic retinopathy
big data
deep learning
endothelial cells
small molecule
chronic lymphocytic leukemia